v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash $ 1,384,697 $ 1,038,952
Prepaid insurance 17,085 20,898
Other prepaid expenses 112,446 85,653
Total assets 1,514,228 1,145,503
Current liabilities:    
Accounts payable and accrued expenses, including $0 and $27,500 to related parties at March 31, 2025 and December 31, 2024, respectively 112,476 83,206
Research and development contract liabilities 242,622 235,078
Total current liabilities 355,098 318,284
Commitments and contingencies
Stockholders’ equity:    
Preferred Stock, $0.0001 par value; authorized – 10,000,000 shares; issued and outstanding – 350,000 shares of Series A Convertible Preferred Stock, $10.00 per share stated value, liquidation preference based on assumed conversion into common shares – 72,917 shares at March 31, 2025 and December 31, 2024 3,500,000 3,500,000
Common stock, $0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 2,684,074 sharers and 2,249,290 shares at March 31, 2025 and December 31, 2024, respectively 268 225
Additional paid-in capital 50,436,110 49,394,687
Accumulated deficit (52,777,248) (52,067,693)
Total stockholders’ equity 1,159,130 827,219
Total liabilities and stockholders’ equity $ 1,514,228 $ 1,145,503

Source

HTML PDF
ZIP